Structured evidence table for Vitamin K2 Blood Pressure Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Vitamin K2 Blood Pressure Randomized Trial | Background/Objectives : Obesity in young adults is a major public health concern and a key contributor to cardiometabolic risk. | 2 | Olivares-Ochoa XC (2026) | Vitamin K2 Supplementation Reduces Cardiometabolic Risk Factors in Young Adults with Overweight and Obesity-A Randomized Placebo-Controlled Trial. |
| Vitamin K2 Blood Pressure Randomized Trial | Vitamin K2 (VK2) has been proposed as a potential adjuvant therapy; however, evidence from randomized controlled trials remains limited. | 2 | Olivares-Ochoa XC (2026) | Vitamin K2 Supplementation Reduces Cardiometabolic Risk Factors in Young Adults with Overweight and Obesity-A Randomized Placebo-Controlled Trial. |
| Vitamin K2 Blood Pressure Randomized Trial | This study evaluated the effect of VK2 supplementation on cardiometabolic risk factors in young adults with overweight or obesity. | 2 | Olivares-Ochoa XC (2026) | Vitamin K2 Supplementation Reduces Cardiometabolic Risk Factors in Young Adults with Overweight and Obesity-A Randomized Placebo-Controlled Trial. |
| Vitamin K2 Blood Pressure Randomized Trial | Vitamin D deficiency has been consistently associated with adverse outcomes, including increased susceptibility to cancers, diabetes, hypertension, and cardiovascular disease [,]. | 3 | D’Elia Saverio (2025) | Modulation of Cardiometabolic Risk by Vitamin D and K2: Simple Supplementation or Real Drug? Uncovering the Pharmacological Properties |
| Vitamin K2 Blood Pressure Randomized Trial | Epidemiological studies further indicate that populations in regions with higher sun exposure exhibit lower prevalence of deficiency and reduced mortality from chronic disease [,]. | 3 | D’Elia Saverio (2025) | Modulation of Cardiometabolic Risk by Vitamin D and K2: Simple Supplementation or Real Drug? Uncovering the Pharmacological Properties |
| Vitamin K2 Blood Pressure Randomized Trial | These findings are reinforced by recent large-scale analyses: for example, a 2023 study in Clinical Nutrition involving nearly 410,000 UK Biobank participants reported that individuals with severe deficiency (<30 nmol/L) had a 10% increased risk of atherosclerotic cardiovascular disease and up to 35% higher risk of cardiovascular mortality []. | 3 | D’Elia Saverio (2025) | Modulation of Cardiometabolic Risk by Vitamin D and K2: Simple Supplementation or Real Drug? Uncovering the Pharmacological Properties |
| Vitamin K2 Blood Pressure Randomized Trial | 1 2 3 4 5 6 7 6 Vitamin D, a pleiotropic secosteroid, exerts physiological effects far beyond its classical roles in calcium homeostasis and skeletal health []. | 3 | D’Elia Saverio (2025) | Modulation of Cardiometabolic Risk by Vitamin D and K2: Simple Supplementation or Real Drug? Uncovering the Pharmacological Properties |
Source documents